| Identification | Back Directory | [Name]
1,2,3,4-Tetrahydroisoquinoline-1,3-dione | [CAS]
4456-77-3 | [Synonyms]
FR 038470
NSC 409146
homophtalic-imide
ine-1,3(2H,4H)-dione
1,3-ISOQUINOLINEDIOL
Isoquinoline-1,3(2H,4H)
4H-Isoquinoline-1,3-dione
2H,4H-1,3-Isoquinolinedione
1,3-[2H,4H]-Isoquinolinedione
2,4-dihydroisoquinoline-1,3-dione
Isoquinoline-1,3(2H,4H)-dione, >=98%
1,2,3,4-Tetrahydroisoquinoline-1,3-dione | [EINECS(EC#)]
1533716-785-6 | [Molecular Formula]
C9H7NO2 | [MDL Number]
MFCD00234966 | [MOL File]
4456-77-3.mol | [Molecular Weight]
161.16 |
| Chemical Properties | Back Directory | [Melting point ]
223 °C | [Boiling point ]
377.1±35.0 °C(Predicted) | [density ]
1.286±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
10.25±0.20(Predicted) | [Appearance]
Off-white to yellow Solid |
| Hazard Information | Back Directory | [Uses]
Isoquinoline-1,3(2H,4H)-dione can be useful in the discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection in human HeLa cells. | [Synthesis]
O-carboxyphenylacetic acid (20.0 g, 111 mmol) was mixed with finely ground urea (7.33 g, 122 mmol) and the reaction was heated at 175-185 °C for 2 hours. After completion of the reaction, the mixture was cooled and purified by recrystallization from methanol to give 1,3-[2H,4H]-isoquinolinedione (12.0 g, 67% yield) as a white solid with a melting point of 220-222 °C (literature value 3: 236-238 °C). The structure of the product was confirmed by 1H NMR and 13C NMR: 1H NMR ((CD3)2SO) δ 4.09 (3H, s, CH2), 7.44 (1H, d, J = 7.6 Hz, 5-H), 7.51 (1H, t, J = 7.6 Hz, 7-H), 7.70 (1H, td, J = 7.6, 1.2 Hz, 6-H). 8.07 (1H, dd, J = 7.8, 1.1 Hz, 8-H), 11.36 (1H, s, NH); 13C NMR ((CD3)2SO) (HSQC/HMBC) δ 35.92 (4-C), 124.95 (8a-C), 127.16 (7-C), 127.41 (8-C), 127.87 (5-C) , 133.47 (6-C), 136.66 (4a-C), 165.34 (1-C), 170.99 (3-C). | [References]
[1] Liebigs Annalen der Chemie, 1981, # 5, p. 811 - 818
[2] Synthetic Communications, 1998, vol. 28, # 17, p. 3195 - 3200
[3] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 5891 - 5908
[4] Synthetic Communications, 1981, vol. 11, # 6, p. 447 - 454
[5] Patent: EP2441755, 2012, A1. Location in patent: Paragraph 0172 |
|
|